Menu
 

Search abstracts


Antiemetics requiring dosage adjustment in oncologic patients with hepatic impairment

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: MORGADO, Manuel (University of Beira Interior, Health Science Faculty)
  • Co-author(s): Andreia Moura: Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal
    Celine Esperança: Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal
    Fátima Mota: Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal
    Maria Coelho: Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal
    Mariana Bastos: Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal
    Rafaela Esteves: Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal
    Ema Paulino: Portuguese Pharmaceutical Society, Lisbon, Portugal
    Manuel Morgado: Health Science Faculty, University of Beira Interior, Covilhã, Portugal;Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal;Pharmaceutical Services, Hospital Centre of Cova da Beira, Covilhã, Portugal
  • Abstract:

    Background

    Nausea and vomiting induced by chemotherapy is an important side effect that compromises patients' quality of life being necessary to relieve these effects through the administration of antiemetics. Some cancer patients have some degree of hepatic impairment (HI) and dosage adjustment of these drugs are required.

    Methods

    The human drug

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses